Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-08T06:33:35.963Z Has data issue: false hasContentIssue false

Mass spectrometry: a technique of many faces

Published online by Cambridge University Press:  28 November 2016

Maya A. Olshina
Affiliation:
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel
Michal Sharon*
Affiliation:
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel
*
*Author for correspondence: Prof. M. Sharon, Department of Biomolecular Sciences, Weizmann Institute of Science, 234 Herzl St, Rehovot 7610001, Israel. Tel.: +972-8-934-3947; Fax: +972-8-934-6010; Email: michal.sharon@weizmann.ac.il
Rights & Permissions [Opens in a new window]

Abstract

Protein complexes form the critical foundation for a wide range of biological process, however understanding the intricate details of their activities is often challenging. In this review we describe how mass spectrometry (MS) plays a key role in the analysis of protein assemblies and the cellular pathways which they are involved in. Specifically, we discuss how the versatility of mass spectrometric approaches provides unprecedented information on multiple levels. We demonstrate this on the ubiquitin-proteasome proteolytic pathway, a process that is responsible for protein turnover. We follow the various steps of this degradation route and illustrate the different MS workflows that were applied for elucidating molecular information. Overall, this review aims to stimulate the integrated use of multiple mass spectrometry approaches for analyzing complex biological systems.

Information

Type
Review
Copyright
Copyright © Cambridge University Press 2016 
Figure 0

Fig. 1. Overview of the 26S proteasome protein degradation pathway. Proteins are tagged multiple times with Ub, leading to the formation of covalently attached poly-Ub chains on the substrate. These tagged substrates are then directed to the 26S proteasome, where they are recognized, deubiquitinated and unfolded by the 19S RP, followed by translocation to the 20S CP where they are degraded into peptides. For each of these stages the biological questions that were addressed using MS techniques are highlighted.

Figure 1

Fig. 2. MS workflows utilized in the exploration of the proteasomal protein degradation pathway. (a) Absolute quantification of ubiquitination using the AQUA technique, in which synthetic heavy peptides corresponding to the types of Ub-linkages are produced, for example mono-Ub (red), heterogeneous poly-Ub containing K11 and K48 linkages (green), or homotypic poly-Ub containing only K48 linkages (blue). Known quantities of these peptides are then combined with the peptides from the sample under investigation (gray) and analyzed by LC-MS/MS. The synthetic heavy peptide and light analyte peptide will have the same retention time during chromatography, thus eluting in the same peak. The peaks can be individually selected and subject to MS/MS, with the mass difference between the light and heavy peptides now distinguishable. Consequently, the ratio between the native peptide and the isotope labeled AQUA standard peptide enables absolute quantification. (b) Labeling of protein extracts using TMT. Proteins are extracted from several cell lines under investigation, followed by the differential labeling of each extract with a unique isobaric tag. The samples are digested and the produced peptides from each sample pooled together. This mixture is then analyzed by LC-MS/MS with the same peptide from each sample falling under the same m/z peak. Selection of this peak followed by MS/MS leads to fragmentation and separation of the differently tagged peptides. The relative peptide levels from each sample can then be quantified and compared. (c) Label free quantification of isolated protein complexes. In this method the different samples are analyzed separately and compared. Often, the protein complex of interest is extracted from a cell lysate using affinity purification. The complex is then digested and subjected to LC-MS/MS allowing identification of the components of the complex and any modifications they contain. By measuring the intensity or ion counts of the precursor ions and comparing this value across samples, relative quantification is achieved. PCP can then be performed to determine the composition of the protein complexes under investigation. (d) Crosslinking coupled MS of proteins (top) and protein complexes (bottom). The addition of crosslinkers to the proteins of interest will cause the formation of covalent bonds between the crosslinker and two amino acids (black lines). These can be within the same protein or between two different proteins. The crosslinked samples are then digested to produce peptides, some of which will contain the crosslink. Uncrosslinked peptides can be removed during an enrichment step. The crosslinked peptides are then subjected to LC-MS/MS, with specific peak selection and fragmentation allowing the identification of the location of the crosslink, and consequently the determination of the proximity of the amino acids involved. (e) Native MS of intact protein complexes. Whole protein complexes are isolated, purified and subjected to MS analysis. The intact mass of the complex reflects the homogeneity and stability of the sample as well as its subunit stoichiometry. Isolation of peaks followed by MS/MS fragmentation leads to the dissociation of distinct associating proteins or subunits, which can then be individually identified. This step also enables differentiation between core and peripheral subunits as well as revealing protein–protein connectivities.

Figure 2

Fig. 3. Quantification of Ub-linkages using AQUA and LC-MS/MS. (a) Ubiquitin contains seven lysine (K) residues in its primary sequence (highlighted in red) and a C-terminal diglycine (GG) motif (highlighted in blue). Tryptic digestion will cleave after K and R residues, producing unique peptides for mono-Ub (top), K48 poly-Ub (middle) and K63 poly-Ub (bottom) linkages, as well as after the R at the C-terminus of Ub (indicated by arrow), leading to the identifiable –GG motif on K48 and K63 linked peptides. These signature peptides are isotopically labeled and added to a sample at known concentrations, followed by analysis by LC-MS/MS. (b) A representative analysis of a peptide sample containing free K63-linked poly-Ub chains, showing the retention time of K63 linked Ub peptides (boxed in red) during LC-MS. Both the heavy signature peptides and light analyte peptides have the same retention time. (c) SRM (MS/MS) analysis of the K63 peak showing the mass difference between the heavy AQUA peptide and the light analyte peptide. Due to the known concentration of the AQUA peptide added to the sample, the amount of analyte peptide can be quantified. Reproduced and adapted with permission from (Kirkpatrick et al.2006).

Figure 3

Fig. 4. Use of the MS-cleavable crosslinker DSSO to identify a crosslinked peptide between Rpn8 and Rpn11. (a) Structure of DSSO demonstrating the covalent bond formed between each reactive group and K residues from two different proteins (orange and blue). The C-S bonds in the spacer arm which can break during CID are highlighted (dashed orange line). The generated peptide fragments after CID are shown, demonstrating the presence of a thiol (-SH) group on the α-peptide (left) and an alkene (=C) on the β-peptide (right). (b) The MS/MS fragmentation pattern of the produced peptides. The presence of the thiol on the α-peptide (denoted αT2+) and the alkene on the β-peptide (denoted βA2+) is distinguishable due to their characteristic mass relationship (+86 Da and +54 Da, respectively). (c) Sequence determination of each crosslinked peptide in (b) by MS/MS/MS, unambiguously defining the site of the crosslink as K195 of Rpn8 to K208 of Rpn11. Reproduced and adapted with permission from (Kao et al.2012).

Figure 4

Fig. 5. Native MS spectra of 20S proteasome regulators. (a) MS spectra of NQO1 confirming the presence of a homodimer. Each of the charge states is split into three reflecting the presence of three different homodimer populations, namely apoNQO1 or the NQO1 bound to one or two FAD molecules. (b) MS/MS spectra of 20S proteasome alone (top), showing the identification of individual α-subunits of the 20S (blue balls) that have been ejected from the intact 20S proteasome during the CID process. Inset shows the mass spectrum of the intact 20S proteasome centered at 13000 m/z, and the peak selected for further MS/MS analysis is highlighted in red. Comparison with the 20S in the presence of DJ-1 (bottom) reveals additional peaks that correspond in mass to the monomeric form of DJ-1 (yellow balls). By extrapolation, we can therefore conclude that before MS/MS analysis, DJ-1 binds to the 20S proteasome. (c) The high resolving power of the Orbitrap mass spectrometer can distinguish between the small mass differences of the Parkinson's disease missense mutants of DJ-1. Compared with the WT DJ-1, the D149A and A104T DJ-1 mutants differ by −30 Da and +44 Da, respectively. Inset shows the clear separation of the peaks in a single charge state. Reproduced and adapted with permission from (Ben-Nissan et al.2016; Moscovitz et al.2012, 2015).